14-day Premium Trial Subscription Try For FreeTry Free
NYSE:MSTX
Delisted

Mast Therapeutics, Inc Fund Price (Quote)

New York Stock Exchange
Open Broker Account
$0.130
+0 (+0%)
At Close: Jan 16, 2018
Forecast Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days $0.0060 $169.56 Tuesday, 16th Jan 2018 MSTX stock ended at $0.130. During the day the stock fluctuated 0% from a day low at $0.130 to a day high of $0.130.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Mast Therapeutics, Inc prices

Date Open High Low Close Volume
Dec 05, 2016 $0.0820 $0.0860 $0.0800 $0.0800 2 270 372
Dec 02, 2016 $0.0800 $0.0850 $0.0740 $0.0800 4 344 655
Dec 01, 2016 $0.0880 $0.0880 $0.0830 $0.0900 3 412 661
Nov 30, 2016 $0.0900 $0.0930 $0.0850 $0.0900 5 391 502
Nov 29, 2016 $0.0970 $0.0990 $0.0900 $0.0900 4 811 313
Nov 28, 2016 $0.0940 $0.100 $0.0900 $0.100 7 419 068
Nov 25, 2016 $0.0960 $0.0970 $0.0890 $0.0900 3 793 201
Nov 23, 2016 $0.100 $0.100 $0.0860 $0.0900 10 683 467
Nov 22, 2016 $0.101 $0.108 $0.0940 $0.100 26 066 393
Nov 21, 2016 $0.0890 $0.102 $0.0810 $0.100 45 196 074
Nov 18, 2016 $0.0770 $0.0770 $0.0720 $0.0700 2 663 410
Nov 17, 2016 $0.0720 $0.0780 $0.0720 $0.0800 2 320 967
Nov 16, 2016 $0.0750 $0.0800 $0.0750 $0.0800 2 927 941
Nov 15, 2016 $0.0800 $0.0800 $0.0760 $0.0800 2 974 982
Nov 14, 2016 $0.0800 $0.0850 $0.0760 $0.0800 3 754 254
Nov 11, 2016 $0.0780 $0.0870 $0.0780 $0.0800 5 087 613
Nov 10, 2016 $0.0740 $0.0790 $0.0700 $0.0800 4 774 359
Nov 09, 2016 $0.0700 $0.0740 $0.0690 $0.0700 3 343 244
Nov 08, 2016 $0.0780 $0.0780 $0.0700 $0.0700 2 155 355
Nov 07, 2016 $0.0800 $0.0800 $0.0700 $0.0700 3 445 200
Nov 04, 2016 $0.0800 $0.0800 $0.0800 $0.0800 3 498 800
Nov 03, 2016 $0.0800 $0.0900 $0.0800 $0.0800 8 951 000
Nov 02, 2016 $0.0700 $0.0800 $0.0700 $0.0700 2 478 900
Nov 01, 2016 $0.0800 $0.0800 $0.0700 $0.0700 6 302 800
Oct 31, 2016 $0.0800 $0.0800 $0.0800 $0.0800 2 698 100
Click to get the best stock tips daily for free!

About Mast Therapeutics, Inc

Mast Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for serious or life-threatening diseases with significant unmet needs. The company’s lead product candidate is MST-188 (vepoloxamer), an injection used for the treatment of sickle cell disease, arterial disease, and heart failure. It also develops AIR001, a sodium nitrite solution for intermittent inhalation via nebulizer, as well as for the treatment of hear... MSTX Profile

Golden Star

Ticker Date Change Price
VCSH May 03 0.0130% $76.93
BNDX May 03 0.349% $48.68
BBCA May 03 1.26% $65.44
ISTB May 03 0.0425% $47.11
ADTH May 03 5.56% $3.24
WMT May 03 1.34% $59.82
UNP May 03 0.84% $240.36
INGR May 03 1.75% $114.56
ASH May 03 2.26% $95.85
WU May 03 0.449% $13.37
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT